Sales grew 38% year over year, driven by volume growth from weight-loss and diabetes drugs Zepbound and Mounjaro, Lilly said.

(PTON) on Thursday reported fiscal fourth-quarter net income of $21.6 million. On a per-share basis, the New York-based company said it had ...

Ranpak Holdings reported Q2 results on August 5 and the shares closed up 19.5%. Despite recent profitability challenges, see ...

It's been a sad week for Organon & Co. ( NYSE:OGN ), who've watched their investment drop 13% to US$8.72 in the ...

A slew or company results were causing big market moves ahead of the opening bell Thursday, and for many, earnings-beat wasn’t enough to prevent a selloff.

Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...

New, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.

U.S. stock earnings have topped expectations and several companies have upped their forecasts, including Disney and Honda Motor.

Prestige Consumer Healthcare expects full-year earnings to be $4.50 to $4.58 per share, with revenue in the range of $1.1 billion to $1.12 billion. This story was generated by Automated Insights ( ...

Dentsply expects full-year earnings in the range of $1.80 to $2 per share, with revenue in the range of $3.6 billion to $3.7 billion. This story was generated by Automated Insights ( ...

So far this earnings season, companies in the S&P 500 that miss Wall Street's estimates for earnings per share and sales have ...

Reaffirms Full Year 2025 GuidanceSecond Quarter 2025 Highlights1Revenues of $390.6 millionNet Income of $0.3 million, a net income margin of 0.1%, includes $7.3 million of expenses related to the ...